Back to results
US 2025/0152572 A1Published application
Nicotine formulation
AssigneeInhaler Supplies Pty Ltd
InventorsDavid Andrew LEWIS, Robert David JOHNSON, Paul Michael YOUNG
Life of this patent
Estimating the term…
Abstract
This disclosure relates to an improved inhalable formulation comprising nicotine, or a pharmaceutically acceptable derivative or salt thereof, a propellant, a C1 to C6 alcohol and a glycol. The disclosure further relates to a metered dose inhaler containing the inhalable nicotine formulation and a method of treating a nicotine addiction with the formulation.
Claims20
An inhalable formulation comprising:
- nicotine, or a pharmaceutically acceptable derivative or salt thereof;
- at least 90% w/w of a propellant;
- between 2%-8% w/w of a C1 to C6 alcohol;
- and
- between 1.5%-5% w/w of a glycol.
2 more elements
A metered dose inhaler comprising an inhalable formulation, said inhalable formulation comprising:
- nicotine, or a pharmaceutically acceptable derivative or salt thereof;
- at least 90% w/w of a propellant;
- between 2%-8% w/w of a C1 to C6 alcohol;
- and
- between 1.5%-5% w/w of a glycol.
2 more elements
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.